Literature DB >> 24236651

Cerebral vascular malformations in hereditary hemorrhagic telangiectasia.

M Neil Woodall1, Melissa McGettigan, Ramon Figueroa, James R Gossage, Cargill H Alleyne.   

Abstract

OBJECT: Hereditary hemorrhagic telangiectasia (HHT) is a hereditary disorder characterized by mucocutaneous telangiectasias, frequent nosebleeds, and visceral arteriovenous malformations (AVMs). Few reports have outlined the prevalence of the various cerebral vascular malformations found in patients with HHT. The authors set out to define the prevalence of cerebral vascular malformations in a population of HHT patients who underwent imaging with 3-T imaging (MRI/MR angiography [MRA]) of the brain.
METHODS: A retrospective review of prospectively collected data was carried out using a database of 372 HHT patients who were seen and examined at the Georgia Regents University HHT Center and screened with 3-T MRI/MRA. Data were tabulated for numbers and types of vascular malformations in this population.
RESULTS: Arteriovenous malformations were identified in 7.7%, developmental venous anomalies in 4.3%, and cerebral aneurysms in 2.4% of HHT patients. The HHT AVMs tended to be supratentorial, small, and cortical in this series, findings consistent with other recent studies in the literature. An arteriovenous fistula, cavernous malformation, and capillary telangiectasia were identified in 0.5%, 1%, and 1.9% of HHT patients, respectively.
CONCLUSIONS: Few studies have investigated the prevalence of the various vascular malformations found in HHT patients screened with 3-T MRI/MRA of the brain. Hereditary hemorrhagic telangiectasia AVMs are more likely to be multiple and have a tendency toward small size and cortical location. As such, they are often treated using a single-modality therapy.

Entities:  

Mesh:

Year:  2013        PMID: 24236651     DOI: 10.3171/2013.10.JNS122402

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  Neurovascular Manifestations of Hereditary Hemorrhagic Telangiectasia: A Consecutive Series of 376 Patients during 15 Years.

Authors:  W Brinjikji; V N Iyer; V Yamaki; G Lanzino; H J Cloft; K R Thielen; K L Swanson; C P Wood
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-24       Impact factor: 3.825

2.  Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study.

Authors:  James W Donaldson; Tricia M McKeever; Ian P Hall; Richard B Hubbard; Andrew W Fogarty
Journal:  Neurology       Date:  2015-04-10       Impact factor: 9.910

3.  Prevalence of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia: Report from a Single Reference Center.

Authors:  M S Perez Akly; C Vazquez; C H Besada; M J Rodriguez; M F Conde; A R Cajal; V A Peuchot; D Dardik; M M Baccanelli; M M Serra
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

4.  Distribution of Cerebrovascular Phenotypes According to Variants of the ENG and ACVRL1 Genes in Subjects with Hereditary Hemorrhagic Telangiectasia.

Authors:  Eleonora Gaetani; Elisabetta Peppucci; Fabiana Agostini; Luigi Di Martino; Emanuela Lucci Cordisco; Carmelo L Sturiale; Alfredo Puca; Angelo Porfidia; Andrea Alexandre; Alessandro Pedicelli; Roberto Pola
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

5.  Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study.

Authors:  Ali Tayebi Meybodi; Helen Kim; Jeffrey Nelson; Steven W Hetts; Timo Krings; Karel G terBrugge; Marie E Faughnan; Michael T Lawton
Journal:  Neurosurgery       Date:  2018-01-01       Impact factor: 4.654

6.  Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia.

Authors:  E M de Gussem; C P Edwards; A E Hosman; C J J Westermann; R J Snijder; M E Faughnan; J J Mager
Journal:  Orphanet J Rare Dis       Date:  2016-04-22       Impact factor: 4.123

7.  Neuroradiological Manifestations of Hereditary Hemorrhagic Telangiectasia in 139 Japanese Patients.

Authors:  Masaki Komiyama; Aiko Terada; Tomoya Ishiguro; Yusuke Watanabe; Hideki Nakajima; Osamu Yamada; Hiroko Morisaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-06-02       Impact factor: 1.742

8.  European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Omer F Eker; Edoardo Boccardi; Ulrich Sure; Maneesh C Patel; Saverio Alicante; Ali Alsafi; Nicola Coote; Freya Droege; Olivier Dupuis; Annette Dam Fialla; Bryony Jones; Ujwal Kariholu; Anette D Kjeldsen; David Lefroy; Gennaro M Lenato; Hans Jurgen Mager; Guido Manfredi; Troels H Nielsen; Fabio Pagella; Marco C Post; Catherine Rennie; Carlo Sabbà; Patrizia Suppressa; Pernille M Toerring; Sara Ugolini; Elisabetta Buscarini; Sophie Dupuis-Girod; Claire L Shovlin
Journal:  Orphanet J Rare Dis       Date:  2020-06-29       Impact factor: 4.123

9.  Benefits of Treating Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia: A Retrospective Analysis of 14 Patients.

Authors:  M Neil Woodall; Peter Nakaji; Robert F Spetzler
Journal:  World Neurosurg X       Date:  2019-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.